Silver H K, Karim K A, Le Riche J, de Jong G, Spinelli J, Worth A, McLean D I, Gallagher R
Department of Advanced Therapeutics, Cancer Control Agency of British Columbia, Vancouver, Canada.
Int J Cancer. 1989 Jul 15;44(1):31-4. doi: 10.1002/ijc.2910440106.
In a previous multivariate analysis of 151 malignant melanoma patients we identified measured depth of primary lesion (Breslow) and serum N-acetyl-neuraminic acid (NANA) concentration as significant independent predictors of recurrence. Our present study examines the contribution of flow cytometric DNA analysis to prediction of recurrence and survival. Fixed, paraffin-embedded specimens of primary lesions were evaluated from 63 of the previously studied patients. These were prepared for DNA analysis. Of the 28 primaries identified as aneuploid 17 later recurred, while this was true for only 9 of the 35 diploid tumors. On multivariate analysis measured depth was again the most significant predictor of recurrence (p less than 0.001). Additional independent predictors were DNA ploidy (p = 0.02) and NANA (p = 0.05). For survival the independent predictors were measured depth (p = 0.003) and NANA (p = 0.05). Measured depth, DNA ploidy and NANA can be used to construct a model predicting the recurrence risk for stage-I melanoma.
在之前对151例恶性黑色素瘤患者的多变量分析中,我们确定原发性病变的测量深度( Breslow深度)和血清N-乙酰神经氨酸(NANA)浓度是复发的重要独立预测指标。我们目前的研究探讨了流式细胞术DNA分析对复发和生存预测的贡献。对先前研究的63例患者的原发性病变固定石蜡包埋标本进行了评估。这些标本被制备用于DNA分析。在确定为非整倍体的28个原发性病变中,有17个后来复发,而在35个二倍体肿瘤中只有9个复发。在多变量分析中,测量深度再次是复发的最显著预测指标(p<0.001)。其他独立预测指标是DNA倍性(p = 0.02)和NANA(p = 0.05)。对于生存,独立预测指标是测量深度(p = 0.003)和NANA(p = 0.05)。测量深度、DNA倍性和NANA可用于构建预测I期黑色素瘤复发风险的模型。